WillItSurvive
United States · absorbed · United States

Pharmapacks

Defunct Amazon marketplace reseller of health and beauty products, now a liquidation shell.

Little protection left
Assessed 29 July 2026 · Evidence as of 29 July 2026
Not much stands between this business and its pressures.
On the recordSince 29 July 2026 · Checkable from within 6 months of Sept 2025 · Every call on the record Checkpoint: Further rulings or settlement in Delaware fiduciary-duty derivative suit against former officers
The call

Pharmapacks ran entirely inside Amazon's marketplace rules, lost that footing, and liquidated in 2022; only a bankruptcy litigation shell remains.

Pharmapacks bought and resold medicines through Amazon's marketplace, making money on the price differences. The business was entirely dependent on Amazon's rules and algorithms, which Amazon could change or cut off anytime, and the company lost money on almost every sale it made. Amazon eventually squeezed them out, and Pharmapacks filed for bankruptcy in August 2022, shut down completely, sold off its inventory, and now exists only as an empty legal shell dealing with old lawsuits about what the company's leaders did wrong. The one thing that might have changed the picture would have been building their own direct customer base or pharmacy relationships instead of depending completely on Amazon, but they never did that.

Why
01
AI pressure: None apparent. AI repricing and inventory tools reshaped Amazon selling, but Pharmapacks folded before any AI-specific threat could apply to it directly. Could AI do the core job? Yes, likely.
02
Bigger players: Amazon. Entire business ran on Amazon's Buy Box; its review-count rank fell from #1 to #5 in 2022 as sales and margins collapsed. Could a giant copy it? Yes, easily.
03
What protects it. None. The operating business is dead; only a Delaware litigation shell remains.
What would change this call
Any acquisition or relaunch of the Pharmapacks brand by a new owner. Would create a new company requiring fresh evaluation, not a revival of the old one.
Delaware bankruptcy court ruling on fiduciary-duty derivative claims against former officers. Clarifies legal accountability for the collapse but has no bearing on any operating business.
Public data showing which sellers absorbed Pharmapacks' former Amazon review volume and rankings. Would confirm which rivals structurally benefited from its exit.
Key numbers
  • $452M revenue in 2021 (2022-08-30)
  • $112M net loss on that revenue (2022-08-30)
  • Chapter 11 filed, case No. 22-10797 (2022-08-28)
Named risks
  • No operating entity exists; company fully liquidated since August 2022 Chapter 11 filing. Severity: high
  • Ongoing derivative fiduciary-duty litigation against former officers could extend liability exposure. Severity: medium
  • Business model had zero structural moat against platform owner Amazon and AI-driven repricing tools. Severity: high
Rivals, as read in July 2026
RivalDirectionEvidence
Amazonlosing toBusiness fully dependent on Amazon Buy Box algorithm; collapsed into Chapter 11 on 2022-08-28
YETI and Anker (DTC brands)losing toDTC brands displaced reseller models in top Amazon seller rankings by 2024-05-08
ThrasiocontestingAmazon FBA aggregator peer also pursued SPAC listing at up to ~$10B valuation, per third-party reporting
Questions people ask
Is Pharmapacks still operating in 2026?
No. Pharmapacks and parent Packable Holdings filed Chapter 11 in Delaware on August 28, 2022, ceased operations, liquidated about $70M of inventory, and now exist only as a litigation shell called Pack Liquidating, LLC with no revenue or employees.
Why did Pharmapacks fail despite being a $1.1 billion unicorn?
Pharmapacks was a pure Amazon marketplace reseller with no proprietary moat, posting a ~$112M net loss on $452M revenue in 2021, and it collapsed into Chapter 11 on August 28, 2022 after a SPAC merger with Highland Transcend fell through in March 2022.
Could AI have replaced Pharmapacks' business model?
Its core workflows, Buy Box repricing, inventory arbitrage, and listing optimization, were exactly the commoditized tasks AI repricing tools now automate across Amazon third-party sellers, and the company had no proprietary data or lock-in to resist that erosion.
Who is Pharmapacks' biggest competitor or threat?
Amazon itself was the real threat, since Pharmapacks' entire business depended on Amazon's Buy Box algorithm and marketplace rules; DTC brands like YETI and Anker also displaced reseller models in seller rankings by 2024.
Who owns Pharmapacks now?
The renamed entity Pack Liquidating, LLC (formerly Packable Holdings, Chapter 11 Case No. 22-10797) is under Delaware bankruptcy court oversight, with creditor Quality King having bought a substantial share of the liquidated $70M inventory.
Did Pharmapacks ever go public?
No. Parent Packable announced a SPAC merger with Highland Transcend Partners I Corp. in September 2021 implying $1.55-1.9B equity value, but the deal was terminated in March 2022 with a $10M break-up fee, and Pharmapacks filed for bankruptcy five months later.
Timeline
  • 2025-09-05Delaware court issues motion-to-dismiss opinion in fiduciary-duty case against former officers
  • 2022-08-28Packable Holdings and Pharmapacks file Chapter 11 in Delaware, Case No. 22-10797
  • 2022-08-24Company announces shutdown, lays off 138 of ~1,000 staff immediately
  • 2022-03SPAC merger with Highland Transcend Partners terminated, $10M break-up fee incurred
  • 2021-09-09Parent rebrands to Packable, announces SPAC merger implying $1.55-1.9B value
  • 2020-11-20Carlyle Group invests $250M+, valuing Pharmapacks at $1.1 billion
  • 2018Series A raised from supplier-investors Reckitt, McKesson, Sealed Air, Emerson
  • 2010Pharmapacks founded as a single brick-and-mortar pharmacy
Revision history
29 July 2026
First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources